Reportable Segment Information (Tables)

6 Months Ended

Mar. 31, 2016

Segment Reporting [Abstract]

Segment Revenue, Operating Income and Depreciation and Amortization

The table below presents segment revenue, operating income and depreciation and amortization, as follows:

	Three Months Ended						Six Months Ended
	March 31,						March 31,
(Dollars in thousands)	2016			2015			2016			2015
Revenue:
Medical Device	$	11,599		$	10,562		$	23,846		$	21,198
In Vitro Diagnostics		5,100			3,853			9,394			7,422
Total revenue	$	16,699		$	14,415		$	33,240		$	28,620
Operating income:
Medical Device	$	2,322		$	4,696		$	6,152		$	10,212
In Vitro Diagnostics		1,982			931			3,625			2,028
Total segment operating income		4,304			5,627			9,777			12,240
Corporate		(2,064	)		(1,695	)		(3,598	)		(3,274	)
Total operating income	$	2,240		$	3,932		$	6,179		$	8,966
Depreciation and amortization:
Medical Device	$	968		$	295		$	1,457		$	565
In Vitro Diagnostics		204			216			426			430
Corporate		215			195			414			394
Total depreciation and amortization	$	1,387		$	706		$	2,297		$	1,389